Attached files
| file | filename |
|---|---|
| 10-K - IDENIX PHARMACEUTICALS INC | v175493_10k.htm |
| EX-31.2 - IDENIX PHARMACEUTICALS INC | v175493_ex31-2.htm |
| EX-21.1 - IDENIX PHARMACEUTICALS INC | v175493_ex21-1.htm |
| EX-32.1 - IDENIX PHARMACEUTICALS INC | v175493_ex32-1.htm |
| EX-32.2 - IDENIX PHARMACEUTICALS INC | v175493_ex32-2.htm |
| EX-31.1 - IDENIX PHARMACEUTICALS INC | v175493_ex31-1.htm |
| EX-10.49 - IDENIX PHARMACEUTICALS INC | v175493_ex10-49.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statements on Form
S-8 (File Nos. 333-118341, 333-128882 and 333-143620) and Form S-3 (File Nos.
333-127710, 333-129213, 333-153471 and 333-159716) of Idenix Pharmaceuticals,
Inc. of our report dated March 9, 2010 relating to the financial statements and
the effectiveness of internal control over financial reporting, which appears in
this Form 10-K.
/s/
PricewaterhouseCoopers LLP
Boston,
Massachusetts
March 9,
2010